SC 13D

Company

Eledon Pharmaceuticals, Inc.

Filed

January 5, 2017

Accession Number

0001193125-17-002838

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →